Sensome Announces Positive First-in-Human Study Results for Lung Cancer Detection Technology
Sensome has announced positive results from its first-in-human study for an in situ tumor detection technology aimed at lung cancer. This technology represents a significant advancement in the detection and diagnosis of lung tumors.
PARIS–(BUSINESS WIRE)– #cancer–Sensome announces positive first-in-human results for its in situ tumor detection technology for lung cancer.